"Performance and Safety of the Surgical Hemostatic Agent HEMOCOLLAGENE® in Patients Requiring Oral Surgery"

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

March 7, 2022

Study Completion Date

March 7, 2022

Conditions
Oral Hemorrhage
Interventions
DEVICE

HEMOCOLLAGENE® : Sterile absorbable hemostatic sponges based on bovine collagen - class III MD

"HEMOCOLLAGENE® is an absorbable, sterile and hemostatic sponge, composed of type I undenatured, native and lyophilized bovine collagen (0.027 g per sponge).~HEMOCOLLAGENE® will be inserted into oral sites (mainly the alveoli dental) after post-extraction or post-invasive dental surgical procedure, in case of bleeding not controled by usual hemostatic method. HEMOCOLLAGENE® will be let in place and will undergo a complete and natural absorption after several weeks."

Trial Locations (10)

1180

Cabinet Dentaire, Brussels

42300

Cabinet dentaire, Roanne

69001

SCM Chirurgie Dentaire Opéra, Lyon

69003

Cabinet Medical, Lyon

69007

HCL-Hospices Civil de Lyon, Lyon

69008

Cabinet dentaire Grange-Blanche, Lyon

69400

Cabinet dentaire, Villefranche-sur-Saône

69680

Cabinet dentaire, Chassieu

75004

APHP- Hôpital de la Pitié Salpetrière, Paris

4 B-1401

Cabinet Dento Médical, cabinet de Nivelles, Baulers

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Symatese

INDUSTRY

collaborator

Recherche Clinique en Odontologie (ReCOL)

NETWORK

collaborator

EndoData

UNKNOWN

lead

Septodont

INDUSTRY

NCT05171231 - "Performance and Safety of the Surgical Hemostatic Agent HEMOCOLLAGENE® in Patients Requiring Oral Surgery" | Biotech Hunter | Biotech Hunter